74 related articles for article (PubMed ID: 35783277)
1. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
Front Genet; 2022; 13():919638. PubMed ID: 35783277
[No Abstract] [Full Text] [Related]
2. Identification of a potential prognostic model combining pyroptosis-related gene with immune microenvironment for pancreatic ductal adenocarcinoma.
Xie H; Xu J; Zhao Q
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17175-17187. PubMed ID: 37782328
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.
Huang Y; Li L; Kang Z; Luo H; Lin X; Zhao S; Zhang Q; Li Q; Liu H; Li M
Front Biosci (Landmark Ed); 2024 Mar; 29(3):98. PubMed ID: 38538261
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a novel immunological model to predict prognosis in pancreatic ductal adenocarcinoma.
Liu J; He M
Int Immunopharmacol; 2024 May; 134():112266. PubMed ID: 38761784
[TBL] [Abstract][Full Text] [Related]
5. Deciphering fatty acid biosynthesis-driven molecular subtypes in pancreatic ductal adenocarcinoma with prognostic insights.
Xu J; Liu M; Xue J; Lu P
Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38753153
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer.
Duan X; Hou R; Huang Y; Wang C; Liu L; Du H; Shi J
Transl Oncol; 2024 May; 46():101983. PubMed ID: 38797018
[TBL] [Abstract][Full Text] [Related]
7. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract][Full Text] [Related]
8. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma.
Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J
Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861
[TBL] [Abstract][Full Text] [Related]
9. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity.
Wang M; Liu L; Li X; Jiang W; Xiao J; Hao Q; Wang J; Reddy AV; Talbot A; Ikuta S; Tian D; Ren L
J Gastrointest Oncol; 2024 Apr; 15(2):730-746. PubMed ID: 38756638
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic mucinous adenocarcinoma has different clinical characteristics and better prognosis compared to non-specific PDAC: A retrospective observational study.
Liu J; Zhang YJ; Zhou J; Zhang ZJ; Wen Y
Heliyon; 2024 May; 10(9):e30268. PubMed ID: 38720717
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma.
Lin J; Liu P; Sun K; Jiang L; Liu Y; Huang Y; Liu J; Shi M; Zhang J; Wang T; Shen B
Cancer Cell Int; 2024 May; 24(1):177. PubMed ID: 38773440
[TBL] [Abstract][Full Text] [Related]
12. Development of a basement membrane gene signature and identification of the potential candidate therapeutic targets for pancreatic cancer.
Lin K; Xu D; Wang X; Shi J; Gao W
Gland Surg; 2023 Feb; 12(2):263-281. PubMed ID: 36915817
[TBL] [Abstract][Full Text] [Related]
13. An ion channel-based prognostic model identified TRPV2 and GJB3 as immunotherapy determinants in pancreatic cancer.
Mao J; Tian Y; Luo N
Heliyon; 2024 Apr; 10(7):e27301. PubMed ID: 38560261
[TBL] [Abstract][Full Text] [Related]
14. The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data.
Wang W; Chen G; Zhang W; Zhang X; Huang M; Li C; Wang L; Lu Z; Xia J
Hum Genet; 2024 Mar; ():. PubMed ID: 38526745
[TBL] [Abstract][Full Text] [Related]
15. Integrating Tertiary Lymphoid Structure-Associated Genes into Computational Models to Evaluate Prognostication and Immune Infiltration in Pancreatic Cancer.
Ma Y; Li X; Zhang J; Zhao X; Lu Y; Shen G; Wang G; Liu H; Hao J
J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38484172
[TBL] [Abstract][Full Text] [Related]
16. A prognostic score based on long-term survivor unique transcriptomic signatures predicts patient survival in pancreatic ductal adenocarcinoma.
Katsuta E; Huyser M; Yan L; Takabe K
Am J Cancer Res; 2021; 11(9):4294-4307. PubMed ID: 34659888
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients.
Liu W; Huo Y; Yang J; Fu X; Yang M; Tao L; Liu D; Zhang J; Hua R; Sun Y
Oncol Lett; 2018 Jun; 15(6):9287-9292. PubMed ID: 29844826
[TBL] [Abstract][Full Text] [Related]
18. Identification of necroptosis-related diagnostic biomarkers in coronary heart disease.
You H; Han W
Heliyon; 2024 May; 10(9):e30269. PubMed ID: 38726127
[TBL] [Abstract][Full Text] [Related]
19. Excavation of gene markers associated with pancreatic ductal adenocarcinoma based on interrelationships of gene expression.
Zhang ZY; Sun ZJ; Gao D; Hao YD; Lin H; Liu F
IET Syst Biol; 2024 Mar; ():. PubMed ID: 38530028
[TBL] [Abstract][Full Text] [Related]
20. Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer.
Acharjee A; Okyere D; Nath D; Nagar S; Gkoutos GV
Heliyon; 2024 May; 10(10):e31437. PubMed ID: 38803850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
